Barclay Corbus
About Barclay F. Corbus
Barclay F. Corbus (age 58) has served as an independent director of Beyond, Inc. since March 2007. He holds a B.A. in Government from Dartmouth College and an M.B.A. in Finance from Columbia Business School, with core credentials in finance, strategic planning, and capital markets from roles at Clean Energy Fuels, WR Hambrecht + Co., and Donaldson, Lufkin & Jenrette . He is currently a member of the Nominating & Corporate Governance Committee, the Technology Committee, and serves as Chair of the Compensation Committee .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Clean Energy Fuels Corp. (NASDAQ: CLNE) | Senior Vice President (strategic development; renewable fuel project development) | Since Sept 2007 | Strategic planning and renewable fuel project development |
| WR Hambrecht + Co. | Co-CEO; earlier executive roles | Jul 2004–Sept 2007; prior executive roles before 2004 | Capital markets, financing alternatives |
| Donaldson, Lufkin & Jenrette | Investment banking group | Prior to Mar 1999 | Corporate finance and analysis |
| tZERO Group, Inc. | Director | Through Apr 2021 | Oversight of blockchain subsidiary |
| Medici Ventures, Inc. | Director | Through Apr 2021 | Oversight of former blockchain subsidiary |
External Roles
| Entity | Role | Status |
|---|---|---|
| Other public company boards | None disclosed | Board independence matrix shows no other public boards for Corbus |
| Clean Energy Fuels Corp. | Senior Vice President (management role, not director) | Active since Sept 2007 |
| tZERO; Medici Ventures | Director (private/subsidiary boards) | Ended Apr 2021 |
Board Governance
- Independence: The Board determined Corbus is independent under NYSE standards .
- Committee assignments: Compensation Committee Chair; member of Nominating & Corporate Governance and Technology Committees .
- Attendance: Each incumbent director attended at least 75% of Board and committee meetings in 2024; Board held 17 meetings, Audit 11, Compensation 7, Nominating & Governance 6, Technology 2 .
- Lead Independent Director: None designated; non-management directors meet regularly in executive session .
- Declassification: Board declassified in 2024; annual election of all directors beginning in 2025 .
Fixed Compensation
| Component (FY 2024) | Detail | Amount |
|---|---|---|
| Annual cash retainer | Non-employee director annual retainer | $75,000 |
| Committee chair fees | Audit Chair receives +$25,000; no separate fee disclosed for Compensation Chair | N/A for Corbus |
| RSU grants (pro-rated and annual) | 1,650 RSUs on Feb 19, 2024 at $25.89; 10,172 RSUs on May 21, 2024 at $16.79 | 1,650; 10,172 |
| Stock awards (grant-date fair value) | Aggregate RSU fair value for 2024 | $213,506 |
| Total director compensation (cash + equity) | FY2024 total | $288,506 |
Performance Compensation
| Performance-Based Component | Metrics | Status |
|---|---|---|
| None disclosed for directors | N/A | Director compensation consists of cash retainers and time-based RSUs; no performance metrics disclosed |
Other Directorships & Interlocks
| Relationship | Detail |
|---|---|
| Historical subsidiary/portfolio boards | Served on boards of tZERO and Medici Ventures until Apr 2021 |
| Compensation Committee interlocks | None; committee members were independent and had no Item 404 relationships in 2024 |
Expertise & Qualifications
- Substantial experience in finance, management, and strategic planning; specific skills include senior leadership, finance/accounting, global business, environmental sustainability/ESG understanding, and business transformation .
Equity Ownership
| Metric | Detail |
|---|---|
| Beneficial ownership (Record Date: Mar 24, 2025) | 78,174 shares; less than 1% of outstanding shares |
| RSUs held at 12/31/2024 | 11,506 RSUs |
| Shares issuable under stock-based awards within 60 days of Record Date | 10,172 shares included for certain directors (including Corbus) |
| Pledging/arrangements | Company not aware of any pledges or arrangements that may result in change of control |
| Director ownership guidelines | Directors must hold stock equal to 3x annual cash compensation within 5 years (by Jan 23, 2028); as of Dec 31, 2024, each director is in compliance or has additional time |
Governance Assessment
- Committee leadership: As Compensation Committee Chair, Corbus oversees executive and director pay structures; committee comprised solely of independent directors, with no interlocks or related-party relationships in 2024, supporting governance quality .
- Attendance and engagement: Board and committees met frequently in 2024; all directors met the 75% attendance threshold, indicating engagement .
- Independence and conflicts: Board reaffirmed Corbus’ independence; historical considerations included prior roles at tZERO/Medici Ventures and WR Hambrecht + Co.; Board continued to conclude independence; no related-party transactions requiring Item 404 disclosure since Jan 1, 2024 .
- Ownership alignment: Director stock ownership guidelines (3x cash retainer) and ongoing compliance reinforce alignment; RSU-based equity provides at-risk exposure; no pledging observed (positive signal) .
- Shareholder signals: Say-on-pay approval was 89.6% in 2024, suggesting general shareholder support for compensation practices overseen by the committee .
RED FLAGS: None evident for Corbus in 2024–2025 filings—no related-party transactions, no pledging, attendance thresholds met, and Compensation Committee independence affirmed .